Takeda Pharmaceutical Company Limited (TAK)
Company Info
US8740602052
874060205
Oct 27, 2008
Highlights
$48.22B
$0.45
34.04
1.62
$3.53T
$2.02T
$764.83B
$12.29 - $15.39
$16.87
0.16%
2.16
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Takeda Pharmaceutical Company Limited, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Takeda Pharmaceutical Company Limited (TAK) returned 15.71% year-to-date (YTD) and 17.27% over the past 12 months. Over the past 10 years, TAK returned -0.49% annually, underperforming the S&P 500 benchmark at 10.61%.
TAK
15.71%
0.86%
9.74%
17.27%
0.87%
-0.49%
^GSPC (Benchmark)
-3.31%
5.38%
-0.74%
10.90%
14.93%
10.61%
Monthly Returns
The table below presents the monthly returns of TAK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 1.13% | 7.62% | 3.19% | 2.82% | 0.20% | 15.71% | |||||||
| 2024 | 2.31% | -0.07% | -2.77% | -5.83% | 2.06% | -3.07% | 7.26% | 7.28% | -2.26% | -1.97% | -2.30% | -2.79% | -3.02% |
| 2023 | 1.28% | -2.85% | 9.42% | 0.67% | -4.52% | -0.82% | -2.86% | 0.92% | 2.51% | -12.09% | 4.04% | 0.85% | -4.87% |
| 2022 | 6.09% | 5.12% | -4.01% | 1.54% | -0.89% | -2.57% | 4.06% | -5.89% | -3.45% | 1.93% | 11.42% | 5.91% | 19.37% |
| 2021 | -3.13% | -5.22% | 11.64% | -8.54% | 2.34% | -1.52% | -1.96% | 0.55% | 1.12% | -14.41% | -4.78% | 2.10% | -21.64% |
| 2020 | -2.53% | -10.04% | -10.39% | 18.18% | 8.70% | -8.05% | 1.51% | 2.25% | -2.19% | -13.73% | 15.85% | 2.08% | -3.88% |
| 2019 | 18.73% | 0.45% | 4.78% | -10.26% | -7.17% | 4.30% | -0.57% | -4.20% | 3.86% | 4.48% | 12.97% | -2.81% | 23.22% |
| 2018 | 3.69% | -3.54% | -11.88% | -13.11% | -4.76% | 3.47% | 1.44% | -1.56% | 5.82% | -1.26% | -10.90% | -10.53% | -37.24% |
| 2017 | 0.94% | 11.01% | 4.86% | 5.06% | 3.79% | -1.36% | 4.64% | 4.40% | 2.31% | 2.28% | -2.30% | 2.82% | 45.13% |
| 2016 | -3.24% | -1.36% | -1.36% | 5.00% | -9.97% | -0.14% | 5.25% | -2.65% | 11.63% | -6.28% | -7.88% | 0.48% | -11.83% |
| 2015 | 20.91% | 2.39% | 0.17% | 2.60% | -5.53% | -0.21% | 4.42% | -2.99% | -8.26% | 13.26% | -1.33% | 2.41% | 27.59% |
| 2014 | 0.91% | 3.31% | 0.35% | -5.70% | 1.39% | 2.60% | -1.68% | -0.13% | -1.83% | 1.43% | -5.40% | -0.57% | -5.61% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 77, TAK is among the top 23% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Takeda Pharmaceutical Company Limited (TAK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Takeda Pharmaceutical Company Limited provided a 2.17% dividend yield over the last twelve months, with an annual payout of $0.33 per share. The company has been increasing its dividends for 2 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.33 | $0.63 | $0.63 | $0.58 | $0.79 | $0.70 | $0.98 | $1.40 | $1.46 | $1.44 | $1.34 | $1.04 |
Dividend yield | 2.17% | 4.78% | 4.41% | 3.69% | 5.80% | 3.84% | 4.94% | 8.33% | 5.14% | 6.91% | 5.34% | 5.03% |
Monthly Dividends
The table displays the monthly dividend distributions for Takeda Pharmaceutical Company Limited. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| 2024 | $0.00 | $0.00 | $0.30 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.33 | $0.00 | $0.00 | $0.00 | $0.63 |
| 2023 | $0.00 | $0.00 | $0.31 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.32 | $0.00 | $0.00 | $0.00 | $0.63 |
| 2022 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.30 | $0.00 | $0.00 | $0.00 | $0.58 |
| 2021 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.39 | $0.00 | $0.00 | $0.00 | $0.79 |
| 2020 | $0.00 | $0.00 | $0.32 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.38 | $0.00 | $0.00 | $0.00 | $0.70 |
| 2019 | $0.00 | $0.00 | $0.66 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.32 | $0.00 | $0.00 | $0.00 | $0.98 |
| 2018 | $0.00 | $0.00 | $0.70 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.70 | $0.00 | $0.00 | $0.00 | $1.40 |
| 2017 | $0.00 | $0.00 | $0.76 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.71 | $0.00 | $0.00 | $0.00 | $1.46 |
| 2016 | $0.00 | $0.00 | $0.76 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.68 | $0.00 | $0.00 | $0.00 | $1.44 |
| 2015 | $0.00 | $0.00 | $0.69 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.65 | $0.00 | $0.00 | $0.00 | $1.34 |
| 2014 | $0.37 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.67 | $0.00 | $0.00 | $0.00 | $1.04 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Takeda Pharmaceutical Company Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Takeda Pharmaceutical Company Limited was 52.76%, occurring on Mar 18, 2020. The portfolio has not yet recovered.
The current Takeda Pharmaceutical Company Limited drawdown is 31.29%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -52.76% | Jan 29, 2018 | 537 | Mar 18, 2020 | — | — | — |
| -42.78% | Jan 5, 2009 | 44 | Mar 9, 2009 | 404 | Oct 13, 2010 | 448 |
| -21.05% | Apr 26, 2013 | 28 | Jun 5, 2013 | 438 | Mar 3, 2015 | 466 |
| -18.14% | Mar 9, 2015 | 329 | Jun 24, 2016 | 192 | Mar 30, 2017 | 521 |
| -17.77% | Mar 1, 2011 | 193 | Dec 1, 2011 | 182 | Aug 22, 2012 | 375 |
Volatility
Volatility Chart
The current Takeda Pharmaceutical Company Limited volatility is 8.46%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Earnings Per Share
Valuation
The Valuation section provides an overview of how Takeda Pharmaceutical Company Limited is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
PEG Ratio
PS Ratio
PB Ratio
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |